Jump to page content

Sören Lukassen

Contact information
Address:BIH at Charité - Center for Digital Health
Kapelle-Ufer 2
10117 Berlin

E-mail:Soeren.lukassen@bih-charite.de

Topics

Gene set inference
In contrast to traditional bulk sequencing methods for genomics, single-cell sequencing gives insights into the workings of a tissue at unprecedented resolution. However, this mass of oftentimes exceedingly noisy and sparse data can be overwhelming when approached with traditional approaches. We have developed a deep-learning-based tool that helps identify functionally related gene sets in single-cell data as well as the cell types and conditions they are related to, allowing researches to more quickly grasp the processes shaping the tissue they are investigating.

COVID-19
During the COVID-19 pandemic, we worked together with other groups at Hidih, Charité, the University Hospital Leipzig and the DKFZ to deliver some of the first single-cell reference atlases of airways of healthy as well as SARS-CoV-2-positive individuals freely available to the research community, and further used these techniques successfully to demonstrate why some groups of patients are at higher risk of severe COVID-19, while children generally present with less severe disease courses. Beyond scientific curiosity, these projects helped jump-start a phase II clinical trial of a potential drug for the treatment of severe COVID-19.

Other areas
Beyond these two focus areas, we have been involved in a number of different single-cell projects, ranging from spermatogenesis to cardiac arrhythmias, as well as in bioinformatics methods development to support novel techniques for the study of individual cells’ transcriptomes.

Glioblastoma
Several ongoing projects are focused on improving diagnosis and management of glioblastoma, the most common and most aggressive primary brain tumor in adults.

Medical imaging
To plan surgery and radiation therapy, the precise location of organs at risk (OARs) and the gross tumor volume (GTV) needs to be determined from 3D MRI or CT scans. Manually annotating these three-dimensional scans is a time-consuming and tedious task. We provide deep neural networks that can accurately segment OARs and GTVs in a matter of seconds, while achieving a performance comparable to human specialist level.

Moreover, we aim to predict the patient survival time with the goal of forecasting the benefit for a patient of receiving a specific radiotherapy regimen while minimizing dose and maximizing efficacy. To ensure the robustness and interpretability of these predictions, we use multiple data sources like radiological features, radiotherapy data, and clinical metadata.  

Methylomics
DNA Methylation plays a large role in glioblastoma biology, for example through modulation of the levels of DNA repair enzymes that render a tumor resistant to radiotherapy. Different classes of glioblastomas can be distinguished by their methylation pattern, with relevance for prognosis and treatment. In recent years, shallow nanopore-based DNA sequencing has improved to a level where it can be used to get a reliable, but exceedingly sparse image of DNA methylation within a sample. To bring this technique to the clinics, we work on developing and improving machine learning methods that are equipped to deal with this extreme sparsity and can reliably distinguish different classes of glioblastoma.

Multi-omics
Ultimately, we aim to integrate the results of the different subprojects on glioblastoma, creating a unified framework for diagnosis and management of glioblastoma based on a multitude of data modalities.

Team

  • Nabil Jabareen

    PhD student

    Contact information
    Address:Kapelle-Ufer 2
    Phone:450 543134
  • Dongsheng Yuan

    PhD student

    Contact information
    Address:Kapelle-Ufer 2
    Phone:450 543134